Form 4: Health Catalyst Director Julie Larson-Green Reports Vesting of Restricted Stock Units

Health Catalyst, Inc. Director Julie Larson-Green reported the vesting of 3,766 restricted stock units, increasing her direct beneficial ownership to 75,020 shares of common stock.

Summary

• Julie Larson-Green, a Director at Health Catalyst, Inc. (HCAT), reported a change in her beneficial ownership of the company's common stock.
• On June 1, 2025, she acquired 3,766 shares of common stock.
• These shares resulted from the 100% vesting of Restricted Stock Units (RSUs) granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan.
• The vesting occurred in accordance with the terms of the Issuer's Non-Employee Director Compensation Policy.
• Following this transaction, Ms. Larson-Green's direct beneficial ownership of Health Catalyst common stock increased to 75,020 shares.

Sentiment

Score: 6

Explanation: The document reports a routine insider equity award vesting, which is a neutral event but slightly positive as it increases director ownership and aligns interests with shareholders.

Positives

• The vesting of 3,766 Restricted Stock Units (RSUs) for Director Julie Larson-Green indicates a continued alignment of management and director interests with shareholder value.
• The increase in direct beneficial ownership to 75,020 shares demonstrates a significant stake held by a key director.

Negatives

• N/A (This document primarily reports a routine insider transaction, not negative operational or financial news.)

Risks

• N/A (This Form 4 filing does not disclose specific risks to the company's operations or financial health.)

Future Outlook

N/A (This Form 4 filing does not provide forward-looking statements or guidance.)

Management Comments

• N/A (This Form 4 filing does not contain direct quotes or paraphrased statements from company management.)

Industry Context

This Form 4 filing is a routine disclosure of insider stock ownership changes and does not provide broader industry context or trends. It reflects standard compensation practices for non-employee directors in the healthcare technology sector, where equity awards are common for aligning interests.

Comparison to Industry Standards

• N/A (This document does not provide information for comparison to industry standards or specific comparable companies/projects.)

Management Changes

Corporate Governance

Legal Proceedings

• N/A (This document does not report any litigation or regulatory matters.)

Related Party Transactions

• N/A (This document does not disclose any related party dealings.)

Stakeholder Impact

• Shareholders: Increased alignment of director interests with shareholder value due to increased equity ownership.

Next Steps

• N/A (This Form 4 filing does not outline specific future actions, events, or milestones for the company.)

Key Dates

Keywords

Health Catalyst, HCAT, SEC Form 4, Insider Trading, Beneficial Ownership, Restricted Stock Units, RSU, Director Compensation, Equity Award, Stock Vesting